Senvest Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-90,000
Closed -$2.39M 59
2024
Q4
$2.39M Buy
+90,000
New +$2.44M 0.07% 50
2024
Q3
Sell
-381,800
Closed -$10.7M 56
2024
Q2
$10.7M Buy
+381,800
New +$10.5M 0.41% 32
2021
Q2
Sell
-243,800
Closed -$8.83M 102
2021
Q1
$8.83M Buy
+243,800
New +$8.66M 0.28% 51
2020
Q4
Sell
-51,119
Closed -$1.78M 79
2020
Q3
$1.78M Buy
+51,119
New +$1.79M 0.1% 54

Other funds holding PFE

Senvest Management's PFE Position: Q1 2025 in Review

Senvest Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 90,000 shares — an estimated $2.39M sold.

Senvest Management first reported a position in PFE in Q3 2020 and held it in 4 quarters. The position peaked at $10.7M in Q2 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Senvest Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Senvest Management sold 90,000 Pfizer shares in Q1 2025, an estimated $2.39M.
  • Senvest Management first reported a position in Pfizer in Q3 2020 and held it in 4 quarters.
  • Senvest Management's Pfizer position peaked at $10.7M in Q2 2024.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Senvest Management's 13F filing for Q1 2025, filed 14 May 2025.